Focal segmental glomerulosclerosis.
D'Agati VD, Kaskel FJ, Falk RJ.
N Engl J Med. 2011 Dec 22;365(25):2398-411. doi: 10.1056/NEJMra1106556.
Focal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective.
Shabaka A, Tato Ribera A, Fernández-Juárez G.
Nephron. 2020;144(9):413-427. doi: 10.1159/000508099. Epub 2020 Jul 28.
Causes and pathogenesis of focal segmental glomerulosclerosis.
Fogo AB.
Nat Rev Nephrol. 2015 Feb;11(2):76-87. doi: 10.1038/nrneph.2014.216. Epub 2014 Dec 2.
Pathogenesis of Focal Segmental Glomerulosclerosis and Related Disorders.
Altintas MM, Agarwal S, Sudhini Y, Zhu K, Wei C, Reiser J.
Annu Rev Pathol. 2025 Jan;20(1):329-353. doi: 10.1146/annurev-pathol-051220-092001.
Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis.
Angeletti A, Bin S, Magnasco A, Bruschi M, Cravedi P, Ghiggeri GM.
Am J Transplant. 2024 Apr;24(4):688-692. doi: 10.1016/j.ajt.2023.12.010. Epub 2023 Dec 14.
Focal segmental glomerulosclerosis; why does it occur segmentally?
Nagata M, Kobayashi N, Hara S.
Pflugers Arch. 2017 Aug;469(7-8):983-988. doi: 10.1007/s00424-017-2023-x. Epub 2017 Jun 29.
Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation in African Americans: Review of the Current Evidence.
Theophilus UI, John JR, Ihab S, Ahmed H.
Exp Clin Transplant. 2021 Dec;19(12):1245-1256. doi: 10.6002/ect.2020.0542. Epub 2021 Jul 16.
Focal segmental glomerulosclerosis.
Goldszer RC, Sweet J, Cotran RS.
Annu Rev Med. 1984;35:429-49. doi: 10.1146/annurev.me.35.020184.002241.
Immune-mediated entities of (primary) focal segmental glomerulosclerosis.
Braun F, Homeyer I, Alachkar N, Huber TB.
Cell Tissue Res. 2021 Aug;385(2):423-434. doi: 10.1007/s00441-021-03454-3. Epub 2021 Apr 27.
Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.
Shoji J, Mii A, Terasaki M, Shimizu A.
Nephron. 2020;144 Suppl 1:65-70. doi: 10.1159/000510748. Epub 2020 Dec 1.
